View in EDS

233: Impact-DCM: A Randomized, Controlled, Multi-Center Phase II Trial Utilizing Expanded Autologous Bone Marrow As Sole Therapy for Dilated Cardiomyopathy

Saved in:
Bibliographic Details
Title: 233: Impact-DCM: A Randomized, Controlled, Multi-Center Phase II Trial Utilizing Expanded Autologous Bone Marrow As Sole Therapy for Dilated Cardiomyopathy
Authors: Bruckner, B.A.1, Bull, D.2, Hammond, B.3, Ali, G.1, Elmar, B.4, Matthias, L.1, Michael, R.J.1, Perryman, L.1, Smedira, N.5, Lattouf, O.6, Bunge, R.R.1, Patel, A.2
Source: Journal of Heart & Lung Transplantation. Feb2010 Supplement, Vol. 29 Issue 2, pS80-S80. 1p.
Database: Academic Search Ultimate
Description
ISSN:10532498
DOI:10.1016/j.healun.2009.11.244